Jacques L. Moreau
Experienced in Febrile Neutropenia

Jacques L. Moreau

Toulouse, FR 
Experienced in Febrile Neutropenia
Toulouse, FR 
OverviewLocationsClinical Research

Overview

Jacques Moreau practices in Toulouse, France. Mr. Moreau is rated as an Experienced expert by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Viral Gastroenteritis, Crohn's Disease, Ulcerative Colitis, Small Bowel Resection, and Colonoscopy.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Febrile Neutropenia.

Gender
Male

Locations

Toulouse, France
Other Locations
Clermont-ferrand, France
Montpellier, France
Villiers-sur-seine, 79360, France
Nancy, France
Besancon, 25030, France
Avenue Du Professeur Jean Poulhès TSA 50032 31059 Toulouse Cedex 9, Saint-jean-saint-germain, 31059, France
3 Avenue Claude Guillemin, Orleans, 45060, France
UE-1277 Plateforme D'Infectiologie Expérimentale, Secteur 3, Route De Crotelles, Nouzilly, 37380, France
Plouzane, 29280, France
Marseille, France
Dijon, France
2 Avenue Augustin Fresnel, Palaiseau, 91127, France
2 Av. Albert Einstein, Villeurbanne, 69626, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab
Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab
Enrollment Status: Unknown
Publish Date: May 31, 2023
Intervention Type: Drug
Study Drug: Adalimumab
Study Phase: Phase 4
Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis- In-TARGET
Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis- In-TARGET
Enrollment Status: Completed
Publish Date: May 31, 2023
Intervention Type: Drug
Study Drug: Golimumab
Study Phase: Phase 4
A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy
A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy
Enrollment Status: Completed
Publish Date: August 03, 2022
Intervention Type: Drug
Study Drugs: Infliximab, Azathioprine, Mercaptopurine, Methotrexate
Study Phase: Phase 4
Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis
Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis
Enrollment Status: Completed
Publish Date: July 31, 2018
Intervention Type: Procedure
Study Phase: Not Applicable
View 3 Less Clinical Trials

71 Total Publications

NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution.
NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution.
Journal: Clinical and translational radiation oncology
Published: May 16, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Moreau's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile